Document Detail


Prolactinomas in men: a multicentre and retrospective analysis of treatment outcome.
MedLine Citation:
PMID:  22288612     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AIMS: To assess treatment outcome in male patients with micro- and macroprolactinomas. DESIGN: Multicentre and retrospective study. PATIENTS: 88 male patients (15 micro- and 73 macroprolactinomas), aged 40.3 ± 14.7 years were studied. Time of follow-up ranged from 3 to 244 months. METHODS: Clinical, hormonal and radiological data were registered at diagnosis and follow-up. Treatment outcome was evaluated in relation to the modality of therapy (dopamine agonists, surgery and radiation therapy). RESULTS: Dopamine agonists normalized prolactin levels in 73.3% and 65.2% of patients with micro- and macroprolactinomas, respectively. Disappearance of tumour was reached in 53.3% and 28.3% of subjects with micro- and macroprolactinomas, respectively. Tumour absence at last visit was achieved in 7 out of 14 patients with macroprolactinoma and treated by means of dual therapy (dopamine agonists and neurosurgery) and in 9 out of 13 patients with macroprolactinoma managed with triple therapy (dopamine agonists, neurosurgery and radiation therapy). Normalization of prolactin levels at last visit was present in 68.9%, 79.6% and 69.2% of patients treated by medical therapy, dual therapy and triple therapy, respectively (differences not significant). Multivariate logistic regression analysis showed that the time on therapy was the only significant variable related to tumour disappearance. CONCLUSION: We conclude that medical therapy normalizes prolactin and reduces tumour size in the majority of men with prolactinomas. The addition of pituitary surgery with or without radiation therapy does not offer significant advantages over medical therapy with dopamine agonists in male patients with macroprolactinomas. © 2012 Blackwell Publishing Ltd.
Authors:
Pedro Iglesias; Carmen Bernal; Carles Villabona; José C Castro; Francisco Arrieta; Juan J Díez
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-30
Journal Detail:
Title:  Clinical endocrinology     Volume:  -     ISSN:  1365-2265     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Affiliation:
Department of Endocrinology, Hospital Ramón y Cajal, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The therapeutic effect of Rosuvastatin on cardiac remodeling from hypertrophy to fibrosis during the...
Next Document:  Violating the Isolated Pentagon Rule (IPR): Endohedral Non-IPR C(98) Cages of Gd(2)@C(98).